Meth And Cocaine Are Spurring a “Fourth Wave” Of The Overdose Crisis
“It’s not your father’s drug market,” said one expert. “We have a synthetic drug crisis caused by stronger and more potent drugs.” Source: Meth And Cocaine Are Spurring a “Fourth Wave” Of The Overdose...
read moreDrugs Most Frequently Involved in Drug Overdose Deaths: United States, 2011–2016
New STATS FROM Nat'l Center for Health Statistics: In 2011-16, age-adjusted rate of overdose deaths involving heroin more than tripled, but so did rate of overdose deaths involving methamphetamine. https://www.cdc.gov/nchs/data/nvsr/nvsr67/nvsr67_09-508.pdf...
read moreA ‘Beautiful Boy’s’ Struggle: What You Need To Know About Methamphetamine Addiction
In this article, I will explore methamphetamine addiction, its impact on users and their families, and its portrayal in Beautiful Boy through gripping performances by Steve Carrell and Timothée Chalamet. Source: A 'Beautiful Boy's' Struggle: What You Need To Know...
read moreDeveloping Novel Therapeutics for Addiction
InterveXion is a privately-held clinical-stage biopharmaceutical company developing novel product candidates for the treatment of addiction disorders. Our lead clinical asset is IXT-m200, a monoclonal antibody directed against methamphetamine, which acts by re-partitioning methamphetamine away from its sites of action in the CNS. IXT-m200 is being studied in an upcoming Phase 2 proof-of-concept study (STAMPOUT). We are also developing a novel vaccine (IXT-v100) against methamphetamine.
Meth And Cocaine Are Spurring a “Fourth Wave” Of The Overdose Crisis
“It’s not your father’s drug market,” said one expert. “We have a synthetic drug crisis caused by stronger and more potent drugs.” Source: Meth And Cocaine Are Spurring a “Fourth Wave” Of The Overdose...
read moreDrugs Most Frequently Involved in Drug Overdose Deaths: United States, 2011–2016
New STATS FROM Nat'l Center for Health Statistics: In 2011-16, age-adjusted rate of overdose deaths involving heroin more than tripled, but so did rate of overdose deaths involving methamphetamine. https://www.cdc.gov/nchs/data/nvsr/nvsr67/nvsr67_09-508.pdf...
read moreA ‘Beautiful Boy’s’ Struggle: What You Need To Know About Methamphetamine Addiction
In this article, I will explore methamphetamine addiction, its impact on users and their families, and its portrayal in Beautiful Boy through gripping performances by Steve Carrell and Timothée Chalamet. Source: A 'Beautiful Boy's' Struggle: What You Need To Know...
read moreDeveloping Novel Therapeutics for Addiction
InterveXion is a privately-held clinical-stage biopharmaceutical company developing novel product candidates for the treatment of addiction disorders. Our lead clinical asset is IXT-m200, a monoclonal antibody directed against methamphetamine, which acts by re-partitioning methamphetamine away from its sites of action in the CNS. IXT-m200 is being studied in an upcoming Phase 2 proof-of-concept study (STAMPOUT). We are also developing a novel vaccine (IXT-v100) against methamphetamine.